Market Alert: Ukraine Conflict Update and U.S. Policy Risk
Integrated Research Limited (ASX: IRI), a global provider of IT observability solutions, announced its FY25 results with steady pro-forma revenue of AU$74.3 million but an 18% decline in statutory revenue to AU$68.3 million. EBITDA fell 35% to AU$15.9 million, and NPAT halved to AU$13.4 million, though cash at bank rose to AU$40.6 million. Shareholders will receive a fully franked dividend of 2.0 cents per share.
The company advanced its product-led growth strategy, launching High Value Payments, securing major contracts with a top 10 US bank and JP Morgan, and releasing Prognosis Elevate, a hybrid cloud solution. Development milestones included a beta release of its AI product, Iris, and AI-powered innovations from IR Labs. Revenue from new clients grew 31%, and subscription-based revenue surged 77%, though expansion revenue fell sharply. Management emphasized FY26 as a pivotal year for accelerating product commercialization and strengthening sustainable growth foundations.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Aug 26, 2025
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.